Aadi Bioscience, Inc. (AADI) Reports In-Line Q3 EPS

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.46), in-line with the analyst estimate of ($0.46). Revenue for the quarter came in at $7.21 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Huron Consulting Group (HURN) Reiterated at Buy by Benchmark after Investor Call
• H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)